Related Experiment Video

Updated: Aug 8, 2026

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction
14:19

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction

Published on: June 29, 2013

Placenta praevia and intra-uterine growth retardation

J Dommisse

    South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
    |February 23, 1985
    PubMed

    Insights

    Placenta previa cases showed 17.5% of neonates experienced intra-uterine growth retardation. Careful monitoring of fetal growth is crucial during conservative placenta previa management.

    Area of Science:

    • Obstetrics and Gynecology
    • Perinatology
    • Neonatal Health

    Background:

    • Placenta previa is a condition where the placenta partially or completely covers the cervix.
    • Conservative management aims to prolong pregnancy, but potential fetal complications require attention.

    Observation:

    • A study analyzed 297 cases of placenta previa.
    • The incidence of intra-uterine growth retardation (IUGR) among neonates was assessed.

    Findings:

    • Intra-uterine growth retardation was observed in 17.5% of neonates born to mothers with placenta previa.
    • This finding highlights a significant association between placenta previa and impaired fetal growth.

    Implications:

    • Conservative management of placenta previa necessitates vigilant fetal surveillance.
    • Monitoring fetal growth and function is essential to optimize neonatal outcomes in these cases.

    More Related Videos

    A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis06:19

    A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis

    Published on: January 7, 2018

    Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes04:08

    Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes

    Published on: June 27, 2025

    Related Concept Videos

    Teratogenicity01:07

    Teratogenicity

    The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
    Pathophysiology of Diabetes01:20

    Pathophysiology of Diabetes

    Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
    Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
    Mitral Valve Prolapse III: Nursing Management01:19

    Mitral Valve Prolapse III: Nursing Management

    The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...